These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32323895)

  • 101. Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization.
    Zhang Y; Liang L; Li Z; Huang Y; Jiang M; Zou B; Xu Y
    Front Oncol; 2023; 13():1295579. PubMed ID: 38111536
    [TBL] [Abstract][Full Text] [Related]  

  • 102. PARP inhibitors combined with radiotherapy: are we ready?
    Sun C; Chu A; Song R; Liu S; Chai T; Wang X; Liu Z
    Front Pharmacol; 2023; 14():1234973. PubMed ID: 37954854
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons.
    Park S; Choi C; Kim H; Shin YJ; Oh Y; Park W; Cho WK; Kim N
    Breast Cancer Res Treat; 2024 Feb; 203(3):449-461. PubMed ID: 37902934
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The Cellular Response to Complex DNA Damage Induced by Ionising Radiation.
    Wilkinson B; Hill MA; Parsons JL
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902352
    [TBL] [Abstract][Full Text] [Related]  

  • 105. GA-OH enhances the cytotoxicity of photon and proton radiation in HPV
    Chitsike L; Bertucci A; Vazquez M; Lee S; Unternaehrer JJ; Duerksen-Hughes PJ
    Front Oncol; 2023; 13():1070485. PubMed ID: 36845698
    [TBL] [Abstract][Full Text] [Related]  

  • 106. DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival.
    Papalouka C; Adamaki M; Batsaki P; Zoumpourlis P; Tsintarakis A; Goulielmaki M; Fortis SP; Baxevanis CN; Zoumpourlis V
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769087
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma.
    Lei H; He A; Jiang Y; Ruan M; Han N
    Front Oncol; 2022; 12():1031944. PubMed ID: 36338767
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons.
    Bright SJ; Flint DB; Martinus DKJ; Turner BX; Manandhar M; Ben Kacem M; McFadden CH; Yap TA; Shaitelman SF; Sawakuchi GO
    Radiat Res; 2022 Oct; 198(4):336-346. PubMed ID: 35939823
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Radiotherapy and the cellular DNA damage response: current and future perspectives on head and neck cancer treatment.
    Fabbrizi MR; Parsons JL
    Cancer Drug Resist; 2020; 3(4):775-790. PubMed ID: 35582232
    [TBL] [Abstract][Full Text] [Related]  

  • 110. High-Throughput 3D Tumor Spheroid Array Platform for Evaluating Sensitivity of Proton-Drug Combinations.
    Lee DW; Kim JE; Lee GH; Son A; Park HC; Oh D; Jo K; Choi C
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054773
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review.
    Chitsike L; Duerksen-Hughes PJ
    Front Oncol; 2021; 11():730412. PubMed ID: 34490123
    [TBL] [Abstract][Full Text] [Related]  

  • 112. A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond.
    Matsumoto Y; Fukumitsu N; Ishikawa H; Nakai K; Sakurai H
    J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442469
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Models for Translational Proton Radiobiology-From Bench to Bedside and Back.
    Suckert T; Nexhipi S; Dietrich A; Koch R; Kunz-Schughart LA; Bahn E; Beyreuther E
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439370
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The Biological Basis for Enhanced Effects of Proton Radiation Therapy Relative to Photon Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
    Wang L; Fossati P; Paganetti H; Ma L; Gillison M; Myers JN; Hug E; Frank SJ
    Int J Part Ther; 2021; 8(1):3-13. PubMed ID: 34285931
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.
    Taku N; Wang L; Garden AS; Rosenthal DI; Gunn GB; Morrison WH; Fuller CD; Phan J; Reddy JP; Moreno AC; Spiotto MT; Chronowski G; Shah SJ; Mayo LL; Gross ND; Ferrarotto R; Zhu XR; Zhang X; Frank SJ
    Curr Treat Options Oncol; 2021 Jun; 22(6):54. PubMed ID: 34086150
    [TBL] [Abstract][Full Text] [Related]  

  • 116. PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts.
    Weigert V; Jost T; Hecht M; Knippertz I; Heinzerling L; Fietkau R; Distel LV
    BMC Cancer; 2020 Aug; 20(1):775. PubMed ID: 32811446
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Proton and photon radiosensitization effects of niraparib, a PARP-1/-2 inhibitor, on human head and neck cancer cells.
    Wang L; Cao J; Wang X; Lin E; Wang Z; Li Y; Li Y; Chen M; Wang X; Jiang B; Zhang R; Sahoo N; Zhang X; Zhu XR; Myers JN; Frank SJ
    Head Neck; 2020 Sep; 42(9):2244-2256. PubMed ID: 32323895
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Effective Radiosensitization of HNSCC Cell Lines by DNA-PKcs Inhibitor AZD7648 and PARP Inhibitors Talazoparib and Niraparib.
    Mentzel J; Hildebrand LS; Kuhlmann L; Fietkau R; Distel LV
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891817
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints.
    Molkentine JM; Molkentine DP; Bridges KA; Xie T; Yang L; Sheth A; Heffernan TP; Clump DA; Faust AZ; Ferris RL; Myers JN; Frederick MJ; Mason KA; Meyn RE; Pickering CR; Skinner HD
    Int J Radiat Biol; 2021; 97(8):1121-1128. PubMed ID: 32073931
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells.
    Bridges KA; Toniatti C; Buser CA; Liu H; Buchholz TA; Meyn RE
    Oncotarget; 2014 Jul; 5(13):5076-86. PubMed ID: 24970803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.